Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Bain Capital
Biotech
Third Rock-backed Merida unveils with $121M for autoimmune plans
Third Rock has unveiled Merida and its $121 million series A that the firm co-led with Bain Capital Life Sciences and BVF Partners.
James Waldron
Apr 8, 2025 11:03am
Gene therapy biotech secures $150M for eye disease candidates
Apr 2, 2025 7:30am
Wearable defibrillator maker Kestra Medical plots $150M IPO
Feb 26, 2025 12:00pm
Angitia raises $120M series C to fund 3 musculoskeletal trials
Dec 11, 2024 9:40am
Kailera launches with $400M series A, 4 Chinese obesity drugs
Oct 1, 2024 8:30am
Bain unveils $3B fund for life science companies
Sep 10, 2024 11:20am
